OBJECTIVE: Invasive candidiasis (IC) outcomes in intensive care units (ICUs) could be improved by the early administration of antifungals. The Candida Score (CS) prediction rule has been proposed for the selection of patients who could develop IC. Procalcitonin (PCT) levels allow prompt identification of sepsis, but their behavior in the setting of IC is unclear. We hypothesize that PCT could be helpful in the early diagnosis of IC in patients with Candida sp. colonization. DESIGN: Prospective observational study. SETTING: Thirty-six ICUs in Spain, Portugal and France. PATIENTS: Every non-neutropenic critically ill patient hospitalized for more than 7 days without concurrent bacterial infection. The CS was calculated weekly. Serums were collected concomitantly. MEASUREMENTS AND RESULTS: Two hundred twenty PCT levels were measured in 136 patients [neither colonized nor infected (NCNI): n = 73; multifocal colonization (MF): n = 43; MF + IC: n = 20]. Baseline PCT levels were significantly higher in the MF + IC group than in other groups (p = 0.001). In patients with MF, the highest CS value calculated during the patient's stay was the sole independent predictor of IC. The receiver-operating curve analysis showed that the diagnosis values of PCT and CS were comparable (AUROCC = 0.713, and 0.727, respectively). Moreover, PCT increased the positive predictive value of CS from 44.7 to 59.3%. CONCLUSIONS: After 7 days of hospitalization, PCT levels in patients with MF who go on to develop IC are higher than in others. Serum PCT could also improve the predictive value of CS. PCT together with CS could therefore be considered for the assessment of IC risk.
OBJECTIVE:Invasive candidiasis (IC) outcomes in intensive care units (ICUs) could be improved by the early administration of antifungals. The Candida Score (CS) prediction rule has been proposed for the selection of patients who could develop IC. Procalcitonin (PCT) levels allow prompt identification of sepsis, but their behavior in the setting of IC is unclear. We hypothesize that PCT could be helpful in the early diagnosis of IC in patients with Candida sp. colonization. DESIGN: Prospective observational study. SETTING: Thirty-six ICUs in Spain, Portugal and France. PATIENTS: Every non-neutropenic critically illpatient hospitalized for more than 7 days without concurrent bacterial infection. The CS was calculated weekly. Serums were collected concomitantly. MEASUREMENTS AND RESULTS: Two hundred twenty PCT levels were measured in 136 patients [neither colonized nor infected (NCNI): n = 73; multifocal colonization (MF): n = 43; MF + IC: n = 20]. Baseline PCT levels were significantly higher in the MF + IC group than in other groups (p = 0.001). In patients with MF, the highest CS value calculated during the patient's stay was the sole independent predictor of IC. The receiver-operating curve analysis showed that the diagnosis values of PCT and CS were comparable (AUROCC = 0.713, and 0.727, respectively). Moreover, PCT increased the positive predictive value of CS from 44.7 to 59.3%. CONCLUSIONS: After 7 days of hospitalization, PCT levels in patients with MF who go on to develop IC are higher than in others. Serum PCT could also improve the predictive value of CS. PCT together with CS could therefore be considered for the assessment of IC risk.
Authors: Djillali Annane; Philippe Aegerter; Marie Claude Jars-Guincestre; Bertrand Guidet Journal: Am J Respir Crit Care Med Date: 2003-07-15 Impact factor: 21.405
Authors: J Nolla-Salas; A Sitges-Serra; C León-Gil; J Martínez-González; M A León-Regidor; P Ibáñez-Lucía; J M Torres-Rodríguez Journal: Intensive Care Med Date: 1997-01 Impact factor: 17.440
Authors: L Ostrosky-Zeichner; C Sable; J Sobel; B D Alexander; G Donowitz; V Kan; C A Kauffman; D Kett; R A Larsen; V Morrison; M Nucci; P G Pappas; M E Bradley; S Major; L Zimmer; D Wallace; W E Dismukes; J H Rex Journal: Eur J Clin Microbiol Infect Dis Date: 2007-04 Impact factor: 3.267
Authors: P Ramirez; M A Garcia; M Ferrer; J Aznar; M Valencia; J M Sahuquillo; R Menéndez; M A Asenjo; A Torres Journal: Eur Respir J Date: 2007-10-24 Impact factor: 16.671
Authors: Cristóbal León; Sergio Ruiz-Santana; Pedro Saavedra; Beatriz Galván; Armando Blanco; Carmen Castro; Carina Balasini; Aránzazu Utande-Vázquez; Francisco J González de Molina; Miguel A Blasco-Navalproto; Maria J López; Pierre Emmanuel Charles; Estrella Martín; María Adela Hernández-Viera Journal: Crit Care Med Date: 2009-05 Impact factor: 7.598
Authors: Tobias Lahmer; Marlena Messer; Ulrich Mayr; Bernd Saugel; Sebastian Noe; Caroline Schultheiss; Philipp Thies; Christoph Spinner; Simon Nennstiel; Christiane Schwerdtfeger; Veit Phillip; Roland M Schmid; Wolfgang Huber Journal: Mycopathologia Date: 2014-10-28 Impact factor: 2.574
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2010-01-08 Impact factor: 17.440
Authors: L Scudeller; C Viscoli; F Menichetti; V del Bono; F Cristini; C Tascini; M Bassetti; P Viale Journal: Infection Date: 2013-11-25 Impact factor: 3.553